IVZ Stock Overview
Invesco Ltd. is a publicly owned investment manager.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$21.94|
|52 Week High||US$29.71|
|52 Week Low||US$20.47|
|1 Month Change||-3.77%|
|3 Month Change||-12.66%|
|1 Year Change||4.63%|
|3 Year Change||15.35%|
|5 Year Change||-25.65%|
|Change since IPO||222.65%|
Recent News & Updates
Invesco: Further Gains On The Cards
Q3 showed growing AUM, growing sales and adjusted operating margins of over 40%. Chinese business set to drive the next wave of growth for the firm. Despite the run-up in shares, the valuation remains attractive here.
|IVZ||US Capital Markets||US Market|
Return vs Industry: IVZ underperformed the US Capital Markets industry which returned 24.6% over the past year.
Return vs Market: IVZ matched the US Market which returned 7.7% over the past year.
|IVZ Average Weekly Movement||4.7%|
|Capital Markets Industry Average Movement||0.7%|
|Market Average Movement||6.6%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: IVZ is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: IVZ's weekly volatility (5%) has been stable over the past year.
About the Company
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client-focused equity and fixed income portfolios.
Invesco Fundamentals Summary
|IVZ fundamental statistics|
Is IVZ overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IVZ income statement (TTM)|
|Cost of Revenue||US$4.57b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Jan 25, 2022
|Earnings per share (EPS)||2.55|
|Net Profit Margin||17.41%|
How did IVZ perform over the long term?See historical performance and comparison
3.1%Current Dividend Yield
Is Invesco undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IVZ ($22.64) is trading below our estimate of fair value ($69.87)
Significantly Below Fair Value: IVZ is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: IVZ is good value based on its PE Ratio (8.9x) compared to the US Capital Markets industry average (15.2x).
PE vs Market: IVZ is good value based on its PE Ratio (8.9x) compared to the US market (16.9x).
Price to Earnings Growth Ratio
PEG Ratio: IVZ's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: IVZ is good value based on its PB Ratio (0.9x) compared to the US Capital Markets industry average (37.6x).
How is Invesco forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IVZ's earnings are forecast to decline over the next 3 years (-0.7% per year).
Earnings vs Market: IVZ's earnings are forecast to decline over the next 3 years (-0.7% per year).
High Growth Earnings: IVZ's earnings are forecast to decline over the next 3 years.
Revenue vs Market: IVZ's revenue (3% per year) is forecast to grow slower than the US market (9.3% per year).
High Growth Revenue: IVZ's revenue (3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IVZ's Return on Equity is forecast to be low in 3 years time (10%).
How has Invesco performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IVZ has high quality earnings.
Growing Profit Margin: IVZ's current net profit margins (17.4%) are higher than last year (7.9%).
Past Earnings Growth Analysis
Earnings Trend: IVZ's earnings have declined by 7.3% per year over the past 5 years.
Accelerating Growth: IVZ's earnings growth over the past year (138.6%) exceeds its 5-year average (-7.3% per year).
Earnings vs Industry: IVZ earnings growth over the past year (138.6%) exceeded the Capital Markets industry 87.1%.
Return on Equity
High ROE: IVZ's Return on Equity (10.7%) is considered low.
How is Invesco's financial position?
Financial Position Analysis
Short Term Liabilities: IVZ's short term assets ($14.9B) exceed its short term liabilities ($2.3B).
Long Term Liabilities: IVZ's short term assets ($14.9B) exceed its long term liabilities ($14.2B).
Debt to Equity History and Analysis
Debt Level: IVZ's net debt to equity ratio (1.7%) is considered satisfactory.
Reducing Debt: IVZ's debt to equity ratio has reduced from 25.4% to 12.8% over the past 5 years.
Debt Coverage: IVZ's debt is well covered by operating cash flow (79.1%).
Interest Coverage: IVZ earns more interest than it pays, so coverage of interest payments is not a concern.
What is Invesco current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: IVZ's dividend (3%) is higher than the bottom 25% of dividend payers in the US market (1.34%).
High Dividend: IVZ's dividend (3%) is low compared to the top 25% of dividend payers in the US market (3.49%).
Stability and Growth of Payments
Stable Dividend: IVZ's dividends per share have been stable in the past 10 years.
Growing Dividend: IVZ's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (26.1%), IVZ's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: IVZ's dividends in 3 years are forecast to be well covered by earnings (23.2% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Marty Flanagan (61 yo)
Mr. Martin L. Flanagan, CFA, CPA, also known as Marty, is the President, Chief Executive Officer and Director of Invesco Ltd. since August 1, 2005. Previously, Mr. Flanagan served as the Chief Executive Of...
CEO Compensation Analysis
Compensation vs Market: Marty's total compensation ($USD11.75M) is about average for companies of similar size in the US market ($USD11.31M).
Compensation vs Earnings: Marty's compensation has been consistent with company performance over the past year.
Experienced Management: IVZ's management team is considered experienced (4.8 years average tenure).
Experienced Board: IVZ's board of directors are considered experienced (6.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: IVZ insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Invesco Ltd.'s employee growth, exchange listings and data sources
- Name: Invesco Ltd.
- Ticker: IVZ
- Exchange: NYSE
- Founded: 1935
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Implied Market Cap: US$10.442b
- Shares outstanding: 461.21m
- Website: https://www.invesco.com
Number of Employees
- Invesco Ltd.
- Two Peachtree Pointe
- 1555 Peachtree Street, NE, Suite 1800
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/21 23:14|
|End of Day Share Price||2022/01/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.